GEODE CAPITAL MANAGEMENT, LLC - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 20 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2017. The put-call ratio across all filers is 3.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q2 2018$6,000
-14.3%
13,7560.0%0.00%
Q1 2018$7,000
-36.4%
13,7560.0%0.00%
Q4 2017$11,000
-15.4%
13,7560.0%0.00%
Q3 2017$13,000
-53.6%
13,7560.0%0.00%
Q2 2017$28,000
-37.8%
13,756
-23.6%
0.00%
Q1 2017$45,000
+15.4%
18,001
+30.9%
0.00%
Q4 2016$39,000
+34.5%
13,7560.0%0.00%
Q3 2016$29,000
+38.1%
13,7560.0%0.00%
Q2 2016$21,00013,7560.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q2 2017
NameSharesValueWeighting ↓
Atria Investments, Inc 67,727$106,0000.01%
Argent Trust Co 15,121$23,0000.01%
Acrospire Investment Management LLC 3,700$6,0000.00%
IFP Advisors, Inc 13$00.00%
Advisor Group, Inc. 5,255$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 13,756$21,0000.00%
Citadel Advisors 14,492$22,0000.00%
Parallax Volatility Advisers, L.P. 50,000$78,0000.00%
Cutler Group LLC / CA 3,700$5,0000.00%
MORGAN STANLEY 59,400$92,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders